BCLS ACQUISITION CORP's ticker is BLSA and the CUSIP is G0904B105. A total of 47 filers reported holding BCLS ACQUISITION CORP in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $197,000 | +0.5% | 19,888 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $196,000 | 0.0% | 19,888 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $196,000 | -1.5% | 19,888 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $199,000 | -13.5% | 19,888 | -8.9% | 0.00% | 0.0% |
| Q2 2021 | $230,000 | -3.4% | 21,826 | -3.2% | 0.00% | 0.0% |
| Q1 2021 | $238,000 | +0.4% | 22,556 | +4.7% | 0.00% | -33.3% |
| Q4 2020 | $237,000 | – | 21,538 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 843,122 | $8,878,000 | 3.55% |
| Finepoint Capital LP | 603,429 | $6,354,000 | 1.19% |
| COMMODORE CAPITAL LP | 250,000 | $2,633,000 | 0.92% |
| Asymmetry Capital Management, L.P. | 83,277 | $877,000 | 0.60% |
| SPHERA FUNDS MANAGEMENT LTD. | 687,900 | $7,244,000 | 0.49% |
| Samsara BioCapital, LLC | 300,000 | $3,159,000 | 0.39% |
| Bain Capital Life Sciences Investors, LLC | 487,500 | $5,133,000 | 0.34% |
| First Trust Capital Management L.P. | 191,272 | $2,014,000 | 0.30% |
| Altium Capital Management LP | 100,000 | $1,053,000 | 0.24% |
| RA Capital Management | 1,250,000 | $13,163,000 | 0.21% |